From chemotherapy and radiotherapy to molecular targeted therapy  in recent decades  we have witnessed the acceleration of cancer treatments However  nowadays  it has encountered obstacles due to multi-drug resistance  drug-induced toxicity and the insufficient disruption of cancer pathways